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Human skin microflora is composed by resident1 temporarily resident and transient microbial species. 
Therefore, gram-positive bacteria from the genera Propionibacterium, Staphylococcus, Micrococcus, 
Corynebaderium and Acinetobacter are the majority microorganisms present in t he res ident microflora 
[1 ]. For instance, Staphylococcus epidermidis is the ma in constit uent of skin microflora, which protects 
the human skin from infections; whereas Staphylococcus aureus is a common transient species, which 
causes skin infections [2]. Anti-bacterial preservatives such as triclosan, methylparaben or bronopol, 
among others, are current ly used as ingredients in the skin and oral care cosmetic products. However, 
there is a growing demand fo r cosmetics free of synthetic preservatives [3]. In this sense, biosurfactants 
from lactic acid bacteria, which are generally recognized as safe by the American Food and Drug 
Administration, are natural compounds that exhibit antimicrobial activity and therefore, could be used 
as an alternative to the chemically synthetized preservatives. The aim of this study was to evaluate the 
antimicrobial activity of biosurfactants obtained from two different Lactobacillus strains (L. pentosus and 
L. paracasef) against skin pathogenic microorganisms. The biosurfactants were obtained according to 
the procedures described by Vecino et al. [4] and Gudina et al. [5]. Afterwards, antimicrobial assays were 
carried out following the method proposed by Gudina et al. [5]. The L. paracasei biosurfactant showed a 
considerable antimicrobial activity against 5. aureus (around 83% at the highest concentration tested, 50 
mg/ml), whereas the L. pentosus biosurfactant was less efficient exhibiting around 67% inhibition against 
the same organism. The same trend was observed against 5. epidermidis, the L. paracasei biosurfactant 
was more efficient (100% inhibition) than the L. pentosus one (40% inhibition). These results are in 
accordance with other studies reported in the literature. For instance, Madhu and Prapulla [6] showed 
that the L. plantarum biosurfactant was able to inhibit the growth of 5. aureus. Gudina and collaborators 
[7] showed that L. agilis biosurfactants exhibit antimicrobial activity against S. aureus (around 20%) at low 
biosurfactant concentrations (5 mg/ml). The results gathered in this study clearly highlight the potential 
of these biosurfactants as preservative ingredients in cosmetic formulations. 
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